Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: From Ron on Yahoo/Ron/Srandl
9
Jul 06, 2008 07:03AM
1
Jul 06, 2008 07:38AM
4
Jul 06, 2008 08:02AM

Sorry I bumped enter on my keyboard before I wanted to.

The point I'm making is that the statistics overwhelmingly support the pantent owner in the ex parte review process.

Also given that 3495 (39%) out of 9060 requests for reexamination were made by patent owners that I don't think it is much of a stretch to think that TPL did not bring up the latest prior art to the attention of the PTO to argue ex parte and ultimately strengthen the patent as well as prove validity.

Also RG stated in one of the shareholder letters that ARM's 584 comments were misleading so the 584 isn't done yet by any stretch of the imagination.

I know RON does not get along with Greeneyes and I don't know if this effort is directed at putting her DD down because of this fact.

All the best,

Steve

Share
New Message
Please login to post a reply